1. Home
  2. ACLS vs VERA Comparison

ACLS vs VERA Comparison

Compare ACLS & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$86.34

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$41.43

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
VERA
Founded
1995
2016
Country
United States
United States
Employees
N/A
249
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
ACLS
VERA
Price
$86.34
$41.43
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$101.50
$81.30
AVG Volume (30 Days)
634.7K
988.9K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.80
N/A
Revenue
$839,048,000.00
N/A
Revenue This Year
$1.93
N/A
Revenue Next Year
$7.91
$445.28
P/E Ratio
$22.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.40
$18.53
52 Week High
$102.93
$56.05

Technical Indicators

Market Signals
Indicator
ACLS
VERA
Relative Strength Index (RSI) 51.84 50.65
Support Level $78.24 $40.87
Resistance Level $91.51 $43.21
Average True Range (ATR) 3.27 2.47
MACD 0.33 0.26
Stochastic Oscillator 74.46 68.89

Price Performance

Historical Comparison
ACLS
VERA

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: